GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) » Definitions » Cyclically Adjusted Price-to-FCF

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Guangdong Taiantang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Guangdong Taiantang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Guangdong Taiantang Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.063/115.2271*115.2271
=0.063

Current CPI (Mar. 2024) = 115.2271.

Guangdong Taiantang Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.134 98.200 -0.157
201409 -0.126 98.900 -0.147
201412 -0.271 99.000 -0.315
201503 -0.238 99.900 -0.275
201506 -0.268 99.500 -0.310
201509 -0.361 100.500 -0.414
201512 -1.285 100.600 -1.472
201603 -0.242 102.200 -0.273
201606 -0.352 101.400 -0.400
201609 -0.207 102.400 -0.233
201612 -0.075 102.600 -0.084
201703 -0.381 103.200 -0.425
201706 -0.265 103.100 -0.296
201709 -0.072 104.100 -0.080
201712 -0.041 104.500 -0.045
201803 -0.138 105.300 -0.151
201806 0.032 104.900 0.035
201809 0.043 106.600 0.046
201812 -0.038 106.500 -0.041
201903 -0.114 107.700 -0.122
201906 0.193 107.700 0.206
201909 0.165 109.800 0.173
201912 0.020 111.200 0.021
202003 -0.316 112.300 -0.324
202006 -0.088 110.400 -0.092
202009 -0.022 111.700 -0.023
202012 0.077 111.500 0.080
202103 0.275 112.662 0.281
202106 0.265 111.769 0.273
202109 0.178 112.215 0.183
202112 0.342 113.108 0.348
202203 0.018 114.335 0.018
202206 0.052 114.558 0.052
202209 0.001 115.339 0.001
202212 0.212 115.116 0.212
202303 -0.053 115.116 -0.053
202306 0.082 114.558 0.082
202309 -0.177 115.339 -0.177
202312 -0.012 114.781 -0.012
202403 0.063 115.227 0.063

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guangdong Taiantang Pharmaceutical Co  (SZSE:002433) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Business Description

Traded in Other Exchanges
N/A
Address
No. 888 North Sichuan Road, 25th Floor, Haitai International Building, Hongkou District, Shanghai, CHN, 200080
Guangdong Taiantang Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, manufacture and sale of high-effect skin-drugs.
Executives
Ke Shao Fang Directors, executives
Hu Qing Guang Director
Song Xiu Qing Director
Ke Shu Quan Director

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Headlines

No Headlines